Samarth Kulkarni - 29 Aug 2024 Form 3 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Samarth Kulkarni
Issuer symbol
ORKA
Transactions as of
29 Aug 2024
Net transactions value
$0
Form type
3
Filing time
06 Sep 2024, 17:06:02 UTC
Previous filing
12 Aug 2024
Next filing
15 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORKA Stock Option (Right to Buy) 29 Aug 2024 Common Stock 142,852 $5.16 Direct F1
holding ORKA Stock Option (Right to Buy) 29 Aug 2024 Common Stock 57,140 $5.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase 142,852 shares of the Issuer's common stock, one quarter of which will vest on March 22, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
F2 This option represents a right to purchase 57,140 shares of the Issuer's common stock, all of which will vest on August 29, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date.

Remarks:

Exhibit 24 - Power of Attorney